Edition:
India

Adamis Pharmaceuticals Announces Submission Of Investigational New Drug (Ind) Application To The FDA


Tuesday, 5 Dec 2017 

Dec 4 (Reuters) - Adamis Pharmaceuticals Corp ::ADAMIS PHARMACEUTICALS ANNOUNCES SUBMISSION OF INVESTIGATIONAL NEW DRUG (IND) APPLICATION TO THE FDA FOR NEW PRODUCT CANDIDATE FOR THE TREATMENT OF OPIOID OVERDOSE. 

Company Quote

1.08
0.05 +4.85%
16 Aug 2019